OA
AVNS

Operose Advisors’s Avanos Medical AVNS Stock Holding History

Operose Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20
Closed -$398 – 580
2024
Q1 		$398 Hold
20
– – ﹤0.01% 639
2023
Q4 		$449 Hold
20
– – ﹤0.01% 588
2023
Q3 		$404 Hold
20
– – ﹤0.01% 742
2023
Q2 		$511 Hold
20
– – ﹤0.01% 345
2023
Q1 		$595 Hold
20
– – ﹤0.01% 333
2022
Q4 		$541 Hold
20
– – ﹤0.01% 348
2022
Q3 		$1K Hold
20
– – ﹤0.01% 325
2022
Q2 		$1K Hold
20
– – ﹤0.01% 290
2022
Q1 		$1K Hold
20
– – ﹤0.01% 307
2021
Q4 		$1K Buy
+20
New +$647 ﹤0.01% 290

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Operose Advisors's AVNS Position: Q2 2024 in Review

Operose Advisors sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 20 shares — an estimated $398 sold.

Operose Advisors first reported a position in AVNS in Q4 2021 and held it in 10 quarters. The position peaked at $1K in Q3 2022. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • Operose Advisors reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • Operose Advisors sold 20 Avanos Medical shares in Q2 2024, an estimated $398.
  • Operose Advisors first reported a position in Avanos Medical in Q4 2021 and held it in 10 quarters.
  • Operose Advisors's Avanos Medical position peaked at $1K in Q3 2022.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Operose Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.